FTC Releases Reports on Cigarette and Smokeless Tobacco Sales and Marketing Expenditures for 2018

Washington, DC - The number of cigarettes that the largest cigarette companies in the United States sold to wholesalers and retailers nationwide declined from 229.1 billion in 2017 to 216.9 billion in 2018, according to the most recent Federal Trade Commission Cigarette Report.

The Trial of Trump and Jesus

Washington, DC - Everything Jesus said and did was twisted by the religious elite of his day to bring charges against him. Charges that amounted to nothing, but they pushed the charges until he was brought to trial where he was found guilty of nothing.

FDA takes efforts to improve quality of compounded drugs from outsourcing facilities through collaboration and education as part of new Center of Excellence

Washington, DC - Compounded drugs can serve an important role in meeting patients’ medical needs that cannot be met by an FDA-approved drug.

FDA approves first generics of Eliquis

Washington, DC - The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.

Texas Health and Human Services Commission Agrees to Pay Over $15 Million to Resolve False Claims Act Liability for Deficient SNAP Quality Control

Washington, DC - The Texas Health and Human Services Commission (THHSC) has agreed to pay the United States $15,294,360 to resolve allegations that it violated the False Claims Act in its administration of the Supplemental Nutrition Assistance Program (SNAP), the Department of Justice announced Monday.